Antimicrobial stewardship for inpatient facilities
- 10 January 2011
- journal article
- review article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 6 (S1) , S4-S15
- https://doi.org/10.1002/jhm.881
Abstract
Antibiotic stewardship aims to improve patient care and reduce unwanted consequences of antimicrobial overuse or misuse, including lowered efficacy, emergence of antimicrobial resistance, development of secondary infections, adverse drug reactions, increased length of hospital stay, and additional healthcare costs. Recent guidelines make specific recommendations for the development of institutional programs to enhance antimicrobial stewardship. Optimally, such programs should be comprehensive, multidisciplinary, supported by hospital and medical staff leadership, and should employ evidence‐based strategies that best fit local needs and resources. An infectious diseases physician and clinical pharmacist with infectious diseases training are recommended as core members of the multidisciplinary team, although a hospitalist with interest (and perhaps additional training) in antimicrobial therapy may be able to fill the void. Program directors and core members should be compensated for their time. Principal proactive strategies—with evidence supporting their consideration—include prospective audits, with intervention and feedback, formulary restriction, and preauthorization. Other strategies include persistent one‐on‐one education, guidelines adapted to local needs, and informatics to support clinical decision making. Intervention goals are to prevent unnecessary antimicrobial starts, to streamline or de‐escalate therapy early in its course, and to convert from parenteral to oral therapy, optimize dosing, and ensure the appropriate length of therapy. Most community hospitals, if sufficiently resourced, should be able to implement a successful antimicrobial stewardship program. Evidence suggests that good antimicrobial stewardship can lead to less overall and inappropriate antimicrobial use, lower drug‐related costs, reductions in Clostridium difficile–associated disease, and, in some studies, less emergence of antimicrobial resistance. Journal of Hospital Medicine 2011;6:S4‐S15 ©2011 Society of Hospital Medicine.Keywords
This publication has 85 references indexed in Scilit:
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic StewardshipClinical Infectious Diseases, 2009
- Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2009
- The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care FacilitiesThe Journals of Gerontology: Series A, 2009
- Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital settingJournal of Antimicrobial Chemotherapy, 2008
- Effect of Communication Errors During Calls to an Antimicrobial Stewardship ProgramInfection Control & Hospital Epidemiology, 2007
- Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004Journal of Clinical Microbiology, 2007
- Evaluation of Antimicrobial Therapy Orders Circumventing an Antimicrobial Stewardship Program: Investigating the Strategy of “Stealth Dosing”Infection Control & Hospital Epidemiology, 2007
- Impact of a Computerized Clinical Decision Support System on Reducing Inappropriate Antimicrobial Use: A Randomized Controlled TrialJournal of the American Medical Informatics Association, 2006
- Inaccurate Communications in Telephone Calls to an Antimicrobial Stewardship ProgramInfection Control & Hospital Epidemiology, 2006